Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
Open Access
- 30 March 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 15 (3), 629-645
- https://doi.org/10.1208/s12248-013-9470-x
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?The Journal of Clinical Pharmacology, 2011
- Quantitative Investigation of the Impact of P-Glycoprotein Inhibition on Drug Transport across Blood-Brain Barrier in RatsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2010
- Effect of Single-Dose Rifampin on the Pharmacokinetics of Warfarin in Healthy VolunteersClinical Pharmacology & Therapeutics, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to RosuvastatinClinical Pharmacology & Therapeutics, 2010
- Calcineurin Inhibitor NephrotoxicityClinical Journal of the American Society of Nephrology, 2009
- Involvement of Multiple Transporters in the Hepatobiliary Transport of RosuvastatinPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2008
- The Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Cross-Talk with Hepatic Nuclear Factor 4α to Synergistically Activate the HumanCYP2C9PromoterJournal of Pharmacology and Experimental Therapeutics, 2005
- Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and futureTrends in Pharmacological Sciences, 2004
- Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.1998